MLBON EURONEXT ACCESS
Euronext Access Paris - BE6333353298 - Stock

05 Sep 2025 10:51 CEST
bonyf NV Cancels Planned Capital Increase Following Positive Strategic Developments

11 Aug 2025 15:16 CEST
Periocream: The Future Commercial Winner for bonyf

03 Jun 2025 17:28 CEST
bonyf Welcomes Group Pharmaceuticals as Strategic Stakeholder to Drive Growth in India

15 May 2025 18:11 CEST
bonyf NV Announces First Exports to the United States with Honest Pharma, Marking a Key Milestone in USA Growth Strategy

08 Apr 2025  10:17 CEST
bonyf Advances to Phase 3 in the Development of Alginate-Organic Denture Fixative Cream

13 Mar 2025 13:45 CET
bonyf recently secures its EU Patent, US patent pending, for PerioTabs® & PerioCream, launch in March 2025 at the IDS Cologne

18 Feb 2025 12:24 CET
bonyf Announces Plans for Dual Listing on Nasdaq and Euronext Paris with a Five-Step Strategy

30 Jan 2025  23:21 CET
bonyf R&D presents its two latest innovations at IDS 2025 in Cologne

10 Dec 2024 15:31 CET
bonyf and Honest Pharma are pleased to announce a Strategic Alliance to bring revolutionary oral care products to the US market

09 Dec 2024 15:42 CET
bonyf Achieves MDR Certification, Strengthening Commitment to Excellence in Oral Care Solutions